Something's brewing, page-39

Please clarify, based on the announcement on 27/4/16, they already enter a BINDING agreement. They only acquired 80% up to date however they can choose to acquire the remaining 20%.

MGC Pharma has executed a binding Heads of Agreement (HOA) to acquire Czech-based medical cannabis company, PANAX Pharma s.r.o. (Panax).
• Under the agreement, MGC Pharma will be issued 25% equity holding in Panax upfront, and will be issued a further 55% of Panax for funding the next year’s operational costs, up to a maximum of €700,000 (total 80% equity interest acquired).
• MGC Pharma holds the rights through an option to acquire the final 20% of Panax for €800,000 in MGC Pharma ordinary shares, based on a 20 day volume weighted average price immediately prior to the issue date.